Table I.
Clinical characteristics of patients with hepatocellular carcinoma included in the present study (n = 60)
Parameter | N |
---|---|
Sex: | |
Male | 33 |
Female | 27 |
Age [years]: | |
≥ 40 | 53 |
< 40 | 7 |
Serum alanine aminotransferase level [U/l]: | |
< 50 | 29 |
≥ 50 | 31 |
Hepatitis B virus surface antigen: | |
Positive | 55 |
Negative 5 (13.9) | 5 |
Serum α-fetoprotein level [ng/ml]: | |
< 400 | 34 |
≥ 400 | 26 |
Length of tumor [cm]: | |
< 5 | 13 |
≥ 5 | 47 |
New American Joint Committee on Cancer stage: | |
Early (I–II) | 39 |
Late (IIIA–IIIB) | 21 |